MediBond

Patna, India Founded: 2022 • Age: 4 yrs
Serves as a distributor of diversified pharmaceutical drugs.

About MediBond

MediBond is a company based in Patna (India) founded in 2022. It operates as a B2B. MediBond operates in a competitive market with competitors including AmerisourceBergen, Entero Healthcare, Keimed, Sandor Medicaids and Mahaveer Medi Sales, among others.

Key Metrics
  • Annual Revenue
    ₹3.03 Cr

    FY 2023 · +518% YoY

  • Net Profit
    ₹1.8 Lakh

    FY 2023 · 1% margin

  • EBITDA
    ₹2.5 Lakh

    FY 2023 · 1% margin

Board of directors of Synstek Internet Private Limited (MediBond)

Synstek Internet Private Limited is the primary company behind MediBond. The board of Synstek Internet Private Limited currently have 2 directors; the longest-serving is Saurabh, appointed in 2019.

DirectorDesignationAppointedTenureEntity
Saurabh
DIN 08637567
Director12 Dec 20196 yrs 9 moSynstek Internet Private Limited
Shubham Kumar
DIN 08637568
Director12 Dec 20196 yrs 9 moSynstek Internet Private Limited

Financials of MediBond

Figures of Synstek Internet Private Limited, the primary company behind MediBond, for FY 2023. Revenue was ₹3.03 Cr (+518% year on year). Net profit was ₹1.8 Lakh (1% margin). EBITDA was ₹2.5 Lakh (1% margin).

  • ₹3.03 CrRevenue · FY 2023 · +518% YoY
  • ₹1.8 LakhNet profit · 1% margin
  • ₹2.5 LakhEBITDA · 1% margin
  • ₹3 LakhPaid-up capital

Balance sheet, profit and loss, cash flow and ratios of Synstek Internet Private Limited are on its company page.

Premium access

Detailed financial statements for MediBond

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Competitors of MediBond

MediBond operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AmerisourceBergen, Entero Healthcare, Keimed, Sandor Medicaids and Mahaveer Medi Sales, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
amerisourcebergen.com1985Chesterbrook, United States–46,000
Pharmaceutical distribution and supply chain services are provided globally.
enterohealthcare.com2018Mumbai, India$59.67M817
India's leading healthcare products distribution platform
keimed.com2000Hyderabad, India$16.62M588
Temperature-sensitive medicines are distributed via cold chain logistics by Keimed.
sandor.co.in1995Hyderabad, India$11.53M161
Provider of medical equipment, devices, and drugs distribution services
mahaveermedi.com2016Bengaluru, India–588
Serves as a distributor of a wide range of pharmaceutical drugs.
dipnapharmachem.com2011Ahmedabad, India––
Distributor of pharmaceutical raw materials
Premium access

Detailed competitors of MediBond

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Similar companies to MediBond

10 companies that operate in the same segment as MediBond (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Pharmaceutical products are manufactured and marketed worldwide.
1891Kenilworth, Warwickshire, United Kingdom–USD 64.93 B781
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
2014New York, New York, United StatesUSD 1.3 BUSD 8.26 M750
Developer of pharmaceutical products for treating multiple diseases
1980Thousand Oaks, California, United States–USD 33.23 B28,000
Biopharmaceutical research and drug development are conducted globally by AbbVie.
2012Chicago, Illinois, United States–USD 61.16 B55,000
Traditional pharmaceutical medicines are developed for multiple health fields.
1876United States–USD 65.18 B47,000
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
1987Foster City, California, United States–USD 29.45 B17,600
Novel therapeutics are discovered using an AI-enabled drug platform.
2013New York, New York, United StatesUSD 456.66 MUSD 74.68 M–
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology.
1993San Francisco, California, United StatesUSD 215.5 MUSD 29.62 M225
Developer of medical devices, generic pharmaceuticals, and nutrition products
1888Libertyville, Illinois, United States–USD 44.33 B3,710
Medicines and health products are retailed through pharmacy outlets.
2006Hyderabad, Telangana, IndiaUSD 268.78 MUSD 734.57 M25,010
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about MediBond

MediBond was founded in 2022.

MediBond is headquartered in Patna, India. It is registered at Patna, Bihar, India.

The primary company behind MediBond, Synstek Internet Private Limited, reported revenue of β‚Ή3.03 Cr for FY 2023, up 518% year on year.

MediBond serves as a distributor of diversified pharmaceutical drugs, focusing on providing healthcare solutions, producing pharmaceutical products, drug distribution, and medical supplies. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets. It continues to evolve, meeting industry challenges with strategic approaches.

MediBond's top competitors include Entero Healthcare, AmerisourceBergen and Keimed.

MediBond operates through Synstek Internet Private Limited.

The legal entities of MediBond currently have 2 directors, including Saurabh, Shubham Kumar.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available